Specifically, physicians should pay attention to the potential decrease in serum copper concentrations in HD patients who receive zinc supplementation, especially in those whose creatinine and transthyretin levels are low, normal, or not much higher than normal. The gene discussed is TTR; the disease is Huntington disease.